Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax’ COVID-19 Vaccine Read more
AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies Read more
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Read more
Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches Read more
Boehringer Ingelheim and Oxford BioTherapeutics Partnership Advances Second Oncology Drug Candidate into the Clinic Read more
Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years Read more
FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ (SB11), LUCENTIS Biosimilar (ranibizumab-nuna) Read more